OOIR: Observatory of International Research

Papers

(The TQCC of Clinics in Liver Disease is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Hepatocellular Carcinoma	179
The Changing Global Epidemiology of Hepatocellular Carcinoma	42
Diagnosis and Management of Hepatic Encephalopathy	34
Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma	32
Noninvasive Detection of Clinically Significant Portal Hypertension in Compensated Advanced Chronic Liver Disease	30
Acute Decompensation and Acute-on-Chronic Liver Failure	30
Role of Biomarkers and Biopsy in Hepatocellular Carcinoma	29
Prevention of First Decompensation in Advanced Chronic Liver Disease	27
Epidemiology of Alcohol-Associated Liver Disease	25
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis	22
Endoscopic Treatment of Esophageal Varices	21
The Role of Hepatic Venous Pressure Gradient in the Management of Cirrhosis	21
Hepatocellular Carcinoma	21
Frailty and Sarcopenia in Patients Pre– and Post–Liver Transplant	21
Current Concepts of Cirrhotic Cardiomyopathy	20
Malnutrition and Alcohol-Associated Hepatitis	20
Evaluation and Management of Pruritus in Primary Biliary Cholangitis	16
Surgical Resection	15
New Treatments for Chronic Hepatitis B Virus/Hepatitis D Virus Infection	15
Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers	15
Overview of Progressive Familial Intrahepatic Cholestasis	15
Biliary Atresia in Children	14
Cardiac and Pulmonary Vascular Risk Stratification in Liver Transplantation	14
Hyponatremia in Cirrhosis	14
Alpha-1 Antitrypsin Deficiency Liver Disease	13

Advances in Hepatocellular Carcinoma	13
Treatment and Prevention of Acute Hepatitis B Virus	13
Alagille Syndrome	13
Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness	13
Bacterial Infections in Cirrhosis as a Cause or Consequence of Decompensation?	13
Obesity Management of Liver Transplant Waitlist Candidates and Recipients	12
Hepatocellular Carcinoma in Primary Biliary Cholangitis	12
Pediatric Liver Transplantation	11
Moderate Alcoholic Hepatitis	11
Role of External Beam Radiotherapy in Hepatocellular Carcinoma	11
Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis	11
Special Population	10
Endoscopic Treatment of Gastric and Ectopic Varices	10
Management of Side Effects of Systemic Therapies for Hepatocellular Carcinoma	10
Lifestyle and Environmental Approaches for the Primary Prevention of Hepatocellular Carcinoma	10
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease	10
Endoscopic Ultrasound-Guided Liver Biopsy	10
Surveillance for Hepatocellular Carcinoma	9
Wilson Disease in Children	9
Chronic Hepatitis B Virus and Hepatitis D Virus	9
Alcohol-Related Liver Disease Including New Developments	9
Beyond Ice and the Cooler	9
Polycystic Kidney/Liver Disease	8
Research Priorities for Precision Medicine in NAFLD	8
Immuno-oncology for Hepatocellular Carcinoma	8
Hepatitis B and Health Care Workers	8
Contemporary Epidemiology of Primary Biliary Cholangitis	8
Genetic and Environmental Susceptibility to Alcoholic Hepatitis	7
The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma	7
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease	7
Invasive Procedures in Patients with Cirrhosis	7
Coronavirus Disease-2019 and Implications on the Liver	7
The Interplay Between Nonalcoholic Fatty Liver Disease and Kidney Disease	7
Simultaneous Liver–Kidney Transplantation	7
An Update on Pediatric Acute Liver Failure	7
Expanding Donor Selection and Recipient Indications for Living Donor Liver Transplantation	7
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease	7
Transplant of Elderly Patients	7
Expanding Role of Donation After Circulatory Death Donors in Liver Transplantation	7
Liver Transplantation for Primary Biliary Cholangitis	7
Imaging Diagnosis of Hepatocellular Carcinoma	7
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma	7
Interpretation of HBV Serologies	7
Primary Biliary Cholangitis	6
Optimizing the Selection of Patients for Simultaneous Liver-Kidney Transplant	6
Emerging Therapies for Alcoholic Hepatitis	6
Hepatorenal Syndrome	6
Controversies in the Management of Hepatitis B	6
Mitochondrial Hepatopathy	6
Liver Transplantation in Acute-on-Chronic Liver Failure	6

Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis	6
Nutritional Evaluation and Treatment of the Cirrhotic Patient	6
Bacterial Infections in Acute on Chronic Liver Failure	5
Treatment of Acute Variceal Bleeding in 2021—When to Use Transjugular Intrahepatic Portosystemic Shunts?	5
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease	5
Hepatitis B and C in Children	5
Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma	5
Hepatorenal Syndrome	5
Nonalcoholic Fatty Liver Disease in Latin America and Australia	5
Novel Therapies That May Cure Chronic Hepatitis B Virus	5
Keeping Patients with End-Stage Liver Disease Alive While Awaiting Transplant	5
Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy	5
Autoantibodies in Primary Biliary Cholangitis	5
Fat Soluble Vitamin Assessment and Supplementation in Cholestasis	5
Post-Transplant Management and Complications of Autoimmune Hepatitis, Primary Biliary Cholangitis, and Primary Sclerosing Cholangitis including Disease Recurrence	5
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease	5
Endoscopic Ultrasound for the Diagnosis and Staging of Biliary Malignancy	5